Atlas Trials

An HIV Vaccine Trial in Individuals Who Started ART During Primary or Chronic Infection

Clinical trial NCT02972450 · TERMINATED

Trial details

NCT number
NCT02972450
Sponsor
ANRS, Emerging Infectious Diseases
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
HIV-1-infection
Start date
2019-02-20
Primary completion
2019-07-11
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.